Aptevo Therapeutics Inc. Share-based Payment Arrangement, Expense
Aptevo Therapeutics Inc. (APVO) reported Share-based Payment Arrangement, Expense of $120.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-14
- Aptevo Therapeutics Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $20.00K.
- Aptevo Therapeutics Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $100.00K, a 50.00% decline year-over-year.
- Aptevo Therapeutics Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was -$4.00K.
- Aptevo Therapeutics Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $80.00K, a 46.31% decline year-over-year.
- Aptevo Therapeutics Inc. share-based payment arrangement, expense for fiscal 2025 was $96.00K, a 91.02% decline from fiscal 2024.
- Aptevo Therapeutics Inc. share-based payment arrangement, expense for fiscal 2024 was $1.07M, a 51.25% decline from fiscal 2023.
- Aptevo Therapeutics Inc. share-based payment arrangement, expense for fiscal 2023 was $2.19M, a 21.70% increase from fiscal 2022.
- Aptevo Therapeutics Inc. share-based payment arrangement, expense for fiscal 2022 was $1.80M, a 9.68% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $120.00K 10-Q · filed 2026-08-14 | $116.00K derived: sum of 3 quarters · filed 2026-08-14 | $196.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-13 | $96.00K derived: sum of 2 quarters · filed 2026-05-13 | $176.00K derived: sum of 3 quarters · filed 2026-05-13 | -$4.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $76.00K derived: sum of 2 quarters · filed 2026-03-26 | -$104.00K derived: sum of 3 quarters · filed 2026-08-14 | $96.00K 10-K · filed 2026-03-26 | |||
| 2025-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$100.00K derived: sum of 2 quarters · filed 2026-08-14 | $100.00K 10-Q · filed 2025-11-06 | $69.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | -$180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $20.00K 10-Q · filed 2026-08-14 | -$11.00K derived: sum of 3 quarters · filed 2026-08-14 | $138.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $200.00K 10-Q · filed 2026-05-13 | $180.00K 10-Q · filed 2025-05-15 | $169.00K derived: sum of 2 quarters · filed 2026-05-13 | $318.00K derived: sum of 3 quarters · filed 2026-05-13 | $591.00K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | -$31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $118.00K derived: sum of 2 quarters · filed 2026-03-26 | $391.00K derived: sum of 3 quarters · filed 2026-03-26 | $1.07M 10-K · filed 2026-03-26 | |||
| 2024-09-30 | $149.00K 10-Q · filed 2024-11-07 | $422.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.10M 10-Q · filed 2025-11-06 | $1.14M 10-Q · filed 2024-11-07 | $1.50M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2024-06-30 | $273.00K 10-Q · filed 2024-08-08 | $1.00M 10-Q · filed 2025-08-11 | $992.00K 10-Q · filed 2024-08-08 | $1.35M derived: sum of 3 quarters · filed 2025-05-15 | $1.80M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2024-03-31 | $719.00K 10-Q · filed 2025-05-15 | $1.08M derived: sum of 2 quarters · filed 2025-05-15 | $1.53M derived: sum of 3 quarters · filed 2025-05-15 | $2.00M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $358.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $813.00K derived: sum of 2 quarters · filed 2025-02-14 | $1.28M derived: sum of 3 quarters · filed 2025-02-14 | $2.19M 10-K · filed 2025-02-14 | |||
| 2023-09-30 | $455.00K 10-Q · filed 2024-11-07 | $920.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.83M 10-Q · filed 2024-11-07 | $2.19M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $465.00K 10-Q · filed 2024-08-08 | $1.38M 10-Q · filed 2024-08-08 | $1.74M derived: sum of 3 quarters · filed 2024-08-08 | $2.10M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $915.00K 10-Q · filed 2024-05-08 | $1.27M derived: sum of 2 quarters · filed 2024-05-08 | $1.63M derived: sum of 3 quarters · filed 2024-05-08 | $2.12M derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | $358.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $717.00K derived: sum of 2 quarters · filed 2024-03-05 | $1.20M derived: sum of 3 quarters · filed 2024-03-05 | $1.80M 10-K · filed 2024-03-05 | |||
| 2022-09-30 | $359.00K 10-Q · filed 2023-11-14 | $843.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.44M 10-Q · filed 2023-11-14 | $1.62M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $484.00K 10-Q · filed 2023-08-10 | $1.08M 10-Q · filed 2023-08-10 | $1.26M derived: sum of 3 quarters · filed 2023-08-10 | $1.58M derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $601.00K 10-Q · filed 2023-05-11 | $780.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.10M derived: sum of 3 quarters · filed 2023-05-11 | $1.67M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $498.00K derived: sum of 2 quarters · filed 2023-03-30 | $1.07M derived: sum of 3 quarters · filed 2023-03-30 | $1.64M 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $319.00K 10-Q · filed 2022-11-10 | $891.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.46M 10-Q · filed 2022-11-10 | $1.66M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $572.00K 10-Q · filed 2022-08-11 | $1.15M 10-Q · filed 2022-08-11 | $1.34M derived: sum of 3 quarters · filed 2022-08-11 | $1.69M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $574.00K 10-Q · filed 2022-05-12 | $772.00K derived: sum of 2 quarters · filed 2022-05-12 | $1.11M derived: sum of 3 quarters · filed 2022-05-12 | $1.42M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $198.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $541.00K derived: sum of 2 quarters · filed 2022-03-24 | $842.00K derived: sum of 3 quarters · filed 2022-03-24 | $1.25M 10-K · filed 2022-03-24 | |||
| 2020-09-30 | $343.00K 10-Q · filed 2021-11-12 | $644.00K derived: sum of 2 quarters · filed 2021-11-12 | $1.06M 10-Q · filed 2021-11-12 | $1.33M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $301.00K 10-Q · filed 2021-08-12 | $714.00K 10-Q · filed 2021-08-12 | $983.00K derived: sum of 3 quarters · filed 2021-08-12 | $1.32M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $413.00K 10-Q · filed 2021-05-11 | $682.00K derived: sum of 2 quarters · filed 2021-05-11 | $1.02M derived: sum of 3 quarters · filed 2021-05-11 | $1.42M derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | $269.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $603.00K derived: sum of 2 quarters · filed 2021-03-31 | $1.00M derived: sum of 3 quarters · filed 2021-03-31 | $1.60M 10-K · filed 2021-03-31 | |||
| 2019-09-30 | $334.00K 10-Q · filed 2020-11-10 | $735.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.33M 10-Q · filed 2020-11-10 | $1.82M derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | $401.00K 10-Q · filed 2020-08-14 | $995.00K 10-Q · filed 2020-08-14 | $1.49M derived: sum of 3 quarters · filed 2020-08-14 | $1.97M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | $594.00K 10-Q · filed 2020-05-13 | $1.09M derived: sum of 2 quarters · filed 2020-05-13 | $1.57M derived: sum of 3 quarters · filed 2020-05-13 | $2.02M derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | $493.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $974.00K derived: sum of 2 quarters · filed 2020-03-25 | $1.42M derived: sum of 3 quarters · filed 2020-03-25 | $2.14M 10-K · filed 2020-03-25 | |||
| 2018-09-30 | $481.00K 10-Q · filed 2019-11-07 | $930.00K derived: sum of 2 quarters · filed 2019-11-07 | $1.65M 10-Q · filed 2019-11-07 | $2.71M derived: sum of 4 quarters · filed 2019-11-07 | |||
| 2018-06-30 | $449.00K 10-Q · filed 2019-08-09 | $1.17M 10-Q · filed 2019-08-09 | $2.23M derived: sum of 3 quarters · filed 2019-08-09 | $3.27M derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | $717.00K 10-Q · filed 2019-05-09 | $1.78M derived: sum of 2 quarters · filed 2019-05-09 | $2.82M derived: sum of 3 quarters · filed 2019-05-09 | $3.92M derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $2.10M derived: sum of 2 quarters · filed 2019-03-18 | $3.21M derived: sum of 3 quarters · filed 2019-03-18 | $4.88M 10-K · filed 2019-03-18 | |||
| 2017-09-30 | $1.04M 10-Q · filed 2018-11-14 | $2.14M derived: sum of 2 quarters · filed 2018-11-14 | $3.82M 10-Q · filed 2018-11-14 | $5.56M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | $1.10M 10-Q · filed 2018-08-09 | $2.78M 10-Q · filed 2018-08-09 | $4.52M derived: sum of 3 quarters · filed 2018-08-09 | $5.85M derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2017-03-31 | $1.68M 10-Q · filed 2018-05-10 | $3.42M derived: sum of 2 quarters · filed 2018-05-10 | $4.75M derived: sum of 3 quarters · filed 2018-05-10 | $5.15M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $3.08M derived: sum of 2 quarters · filed 2018-03-13 | $3.48M derived: sum of 3 quarters · filed 2018-03-13 | $3.81M 10-K · filed 2018-03-13 | |||
| 2016-09-30 | $1.33M 10-Q · filed 2017-11-13 | $1.73M derived: sum of 2 quarters · filed 2017-11-13 | $2.07M 10-Q · filed 2017-11-13 | $4.71M derived: sum of 4 quarters · filed 2017-11-13 | |||
| 2016-06-30 | $400.00K 10-Q · filed 2017-08-10 | $734.00K 10-Q · filed 2017-08-10 | $3.38M derived: sum of 3 quarters · filed 2017-08-10 | $3.66M derived: sum of 4 quarters · filed 2017-08-10 | |||
| 2016-03-31 | $2.69M 10-Q · filed 2017-05-12 | $2.98M derived: sum of 2 quarters · filed 2017-05-12 | $3.26M derived: sum of 3 quarters · filed 2017-05-12 | ||||
| 2015-12-31 | $285.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $566.00K derived: sum of 2 quarters · filed 2017-03-31 | $1.11M 10-K · filed 2017-03-31 | ||||
| 2015-09-30 | $281.00K 10-Q · filed 2016-11-14 | $822.00K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |